{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Post-Traumatic+Neuralgia", "query": { "condition": "Post-Traumatic Neuralgia" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 13, "total_pages": 2, "next_page_url": "https://clinicaltrialsfind.com/api/v1/search.json?condition=Post-Traumatic+Neuralgia&page=2&page_size=10", "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-07-22T20:52:06.347Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT01701362", "title": "Placebo-controlled Safety and Efficacy Study of Pregabalin in Subjects With Post-traumatic Peripheral Neuropathic Pain", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE3" ], "conditions": [ "Neuropathic Pain" ], "interventions": [ { "name": "pregabalin", "type": "DRUG" }, { "name": "placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Pfizer's Upjohn has merged with Mylan to form Viatris Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 542, "start_date": "2012-10", "completion_date": "2015-08", "has_results": true, "last_update_posted_date": "2021-01-28", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 105, "location_summary": "Huntsville, Alabama • Goodyear, Arizona • Phoenix, Arizona + 70 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Goodyear", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" }, { "city": "Phoenix", "state": "Arizona" } ], "official_url": "https://clinicaltrials.gov/study/NCT01701362" }, { "nct_id": "NCT04846010", "title": "Recovering Damaged Cells for Sequelae Caused by COVID-19, SARS-CoV-2", "overall_status": "UNKNOWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1", "PHASE2" ], "conditions": [ "Sequelae of; Infection", "Post Infection Glomerulonephritis", "Post-Infectious Peripheral Neuralgia", "Post-Infectious Disorder (Disorder)", "Post-Infectious Arthritis", "Post-Infectious Polyneuritis", "Post-Infectious Parkinsonism", "Post-Infectious Hypothyroidism", "Post Infectious Osteoarthritis", "Anxiety Disorders", "Depression", "Depression, Anxiety", "Depression, Bipolar", "Insomnia", "GERD", "Gastro Esophageal Reflux", "Hepatitis", "Glomerulonephritis" ], "interventions": [ { "name": "PurWet", "type": "COMBINATION_PRODUCT" }, { "name": "FurFat", "type": "COMBINATION_PRODUCT" }, { "name": "PurApo", "type": "COMBINATION_PRODUCT" }, { "name": "PurPhl", "type": "COMBINATION_PRODUCT" }, { "name": "PurClo", "type": "COMBINATION_PRODUCT" }, { "name": "PurInf", "type": "COMBINATION_PRODUCT" }, { "name": "Smoliv", "type": "COMBINATION_PRODUCT" } ], "intervention_types": [ "COMBINATION_PRODUCT" ], "sponsor": "All Natural Medicine Clinic, LLC", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 2000, "start_date": "2021-03-01", "completion_date": "2022-10-01", "has_results": false, "last_update_posted_date": "2021-05-26", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 1, "location_summary": "Rockville, Maryland", "locations": [ { "city": "Rockville", "state": "Maryland" } ], "official_url": "https://clinicaltrials.gov/study/NCT04846010" }, { "nct_id": "NCT03253523", "title": "Post-traumatic Occipital Neuralgia - Surgical Versus Medical Management", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Post-Traumatic Neuralgia", "Occipital Neuralgia" ], "interventions": [ { "name": "Occipital neurolysis", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Rush University Medical Center", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 0, "start_date": "2019-09-30", "completion_date": "2021-02-01", "has_results": false, "last_update_posted_date": "2021-03-10", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 1, "location_summary": "Chicago, Illinois", "locations": [ { "city": "Chicago", "state": "Illinois" } ], "official_url": "https://clinicaltrials.gov/study/NCT03253523" }, { "nct_id": "NCT00431847", "title": "Regional Anesthesia Military Battlefield Pain Outcomes Study", "overall_status": "COMPLETED", "study_type": "OBSERVATIONAL", "phases": [], "conditions": [ "Anxiety Disorders", "Complex Regional Pain Syndrome Type II", "Depressive Disorders", "Post-Traumatic Stress Disorder", "Substance Abuse" ], "interventions": [ { "name": "Regional Anesthesia", "type": "PROCEDURE" }, { "name": "Standard Pain Management Protocol", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "VA Office of Research and Development", "sponsor_class": "FED", "healthy_volunteers": false, "eligibility": { "minimum_age": null, "maximum_age": null, "sex": "ALL", "summary": "Not listed" }, "enrollment_count": 386, "start_date": "2007-10", "completion_date": "2014-11", "has_results": true, "last_update_posted_date": "2017-05-15", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 3, "location_summary": "Bethesda, Maryland • Philadelphia, Pennsylvania • Fort Sam Houston, Texas", "locations": [ { "city": "Bethesda", "state": "Maryland" }, { "city": "Philadelphia", "state": "Pennsylvania" }, { "city": "Fort Sam Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT00431847" }, { "nct_id": "NCT05491915", "title": "The MONARCH Case Series Study: SPRINT® Peripheral Nerve Stimulation for the Treatment of Head Pain", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Cervicogenic Headache", "Occipital Neuralgia" ], "interventions": [ { "name": "SPRINT Peripheral Nerve Stimulation (PNS) System", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "SPR Therapeutics, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 50, "start_date": "2022-10-24", "completion_date": "2027-08", "has_results": false, "last_update_posted_date": "2026-06-08", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 10, "location_summary": "Santa Rosa, California • Waltham, Massachusetts • Rochester, Minnesota + 7 more", "locations": [ { "city": "Santa Rosa", "state": "California" }, { "city": "Waltham", "state": "Massachusetts" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Austin", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT05491915" }, { "nct_id": "NCT00964990", "title": "A Study to Evaluate the Efficacy, Safety, and Tolerability of JNJ-42160443 in Patients With Neuropathic Pain (Postherpetic Neuralgia and Post-traumatic Neuralgia)", "overall_status": "TERMINATED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Pain", "Neuralgia, Postherpetic", "Neuralgia", "Mononeuropathies" ], "interventions": [ { "name": "JNJ-42160443", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Johnson & Johnson Pharmaceutical Research & Development, L.L.C.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "80 Years", "sex": "ALL", "summary": "18 Years to 80 Years" }, "enrollment_count": 112, "start_date": "2009-09", "completion_date": "2011-07", "has_results": false, "last_update_posted_date": "2016-05-02", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 40, "location_summary": "Tucson, Arizona • Fresno, California • Redondo Beach, California + 37 more", "locations": [ { "city": "Tucson", "state": "Arizona" }, { "city": "Fresno", "state": "California" }, { "city": "Redondo Beach", "state": "California" }, { "city": "Roseville", "state": "California" }, { "city": "Hollywood", "state": "Florida" } ], "official_url": "https://clinicaltrials.gov/study/NCT00964990" }, { "nct_id": "NCT03478735", "title": "Ultrasound Greater Occipital Nerve Block at C2 Level Compared to Landmark-based Greater Occipital Nerve Block", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Occipital Neuralgia", "Cervicogenic Headache", "Migraine Without Aura" ], "interventions": [ { "name": "Ultrasound Guided Greater Occipital Nerve Block at C2", "type": "PROCEDURE" }, { "name": "Landmark-Based Greater Occipital Nerve Block", "type": "PROCEDURE" } ], "intervention_types": [ "PROCEDURE" ], "sponsor": "Mayo Clinic", "sponsor_class": "OTHER", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 32, "start_date": "2017-07-17", "completion_date": "2021-06-14", "has_results": false, "last_update_posted_date": "2021-06-15", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 1, "location_summary": "Rochester, Minnesota", "locations": [ { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT03478735" }, { "nct_id": "NCT04795635", "title": "Axon Therapy for Post-Traumatic Peripheral Neuropathic Pain Compared to Conventional Medical Management", "overall_status": "ACTIVE_NOT_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "NA" ], "conditions": [ "Neuropathic Pain", "Peripheral Neuropathy" ], "interventions": [ { "name": "CMM + Axon Therapy", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "NeuraLace Medical, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 61, "start_date": "2021-04-14", "completion_date": "2024-08-22", "has_results": false, "last_update_posted_date": "2024-07-12", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 3, "location_summary": "Shrewsbury, New Jersey • Winston-Salem, North Carolina • Murrells Inlet, South Carolina", "locations": [ { "city": "Shrewsbury", "state": "New Jersey" }, { "city": "Winston-Salem", "state": "North Carolina" }, { "city": "Murrells Inlet", "state": "South Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT04795635" }, { "nct_id": "NCT07057206", "title": "Simultaneous Engagement of Networks for Alleviating Pain (SENAP)", "overall_status": "NOT_YET_RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Neuropathic Pain", "Postherpetic Neuralgia" ], "interventions": [ { "name": "PFM-guided cortical stimulation", "type": "DEVICE" } ], "intervention_types": [ "DEVICE" ], "sponsor": "University of Minnesota", "sponsor_class": "OTHER", "healthy_volunteers": false, "eligibility": { "minimum_age": "22 Years", "maximum_age": null, "sex": "ALL", "summary": "22 Years and older" }, "enrollment_count": 20, "start_date": "2026-11-01", "completion_date": "2030-12", "has_results": false, "last_update_posted_date": "2026-07-09", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 1, "location_summary": "Minneapolis, Minnesota", "locations": [ { "city": "Minneapolis", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT07057206" }, { "nct_id": "NCT06414356", "title": "The Effect of Outpatient Ketamine Infusion on Chronic Neuropathic Pain and PTSD", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Neuropathic Pain", "PTSD" ], "interventions": [ { "name": "Ketamine", "type": "DRUG" }, { "name": "Magnesium sulfate", "type": "DRUG" }, { "name": "Ketamine + Magnesium sulfate", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Margaux M. Salas, PhD", "sponsor_class": "FED", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "70 Years", "sex": "ALL", "summary": "18 Years to 70 Years" }, "enrollment_count": 30, "start_date": "2024-10-02", "completion_date": "2027-05", "has_results": false, "last_update_posted_date": "2025-02-25", "last_synced_at": "2026-07-22T20:52:06.347Z", "location_count": 1, "location_summary": "San Antonio, Texas", "locations": [ { "city": "San Antonio", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT06414356" } ] }